524743 FISCHER

Fischer Medical Ventures Share Price

₹699.90 +5.2 (0.75%)

29 Dec, 2024 07:51

SIP TrendupStart SIP in FISCHER

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 9.88%
  • Over 3 Month + 10.27%
  • Over 6 Month + 9.88%
  • Over 1 Year + 211.41%
SIP Lightning

Smart Investing Starts Here Start SIP with Fischer Medical Ventures for Steady Growth!

Invest Now

Fischer Medical Ventures Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Fischer Medical Ventures Financials

Fischer Medical Ventures Technicals

EMA & SMA

Current Price
₹699.90
+ 5.2 (0.75%)
pointer
  • stock-down_img
  • Bullish Moving Average 11
  • stock-up_img
  • Bearish Moving Average 5
  • 20 Day
  • ₹688.96
  • 50 Day
  • ₹665.63
  • 100 Day
  • ₹643.97
  • 200 Day
  • ₹576.52

Resistance and Support

708.1 Pivot Speed
  • R3 755.60
  • R2 742.50
  • R1 721.20
  • S1 686.80
  • S2 673.70
  • S3 652.40

What's your outlook on Fischer Medical Ventures?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Fischer Medical Ventures Ltd has an operating revenue of Rs. 70.75 Cr. on a trailing 12-month basis. An annual revenue growth of 11833% is outstanding, Pre-tax margin of 10% is healthy, ROE of 2% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 15% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 12% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 82 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 83 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Fischer Medical Ventures Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-08-14 Quarterly Results & Preferential issue
2024-05-30 Audited Results
2024-05-04 Others
2024-02-12 Quarterly Results

Fischer Medical Ventures F&O

Fischer Medical Ventures Shareholding Pattern

74.91%
5.07%
16.39%
3.63%

About Fischer Medical Ventures

  • NSE Symbol
  • FISCHER
  • BSE Symbol
  • 524743
  • Chairman & Managing Director
  • Mr. Ravindran Govindan
  • ISIN
  • INE771F01025

Similar Stocks to Fischer Medical Ventures

Fischer Medical Ventures FAQs

Fischer Medical Ventures share price is ₹699 As on 29 December, 2024 | 07:37

The Market Cap of Fischer Medical Ventures is ₹3744.5 Cr As on 29 December, 2024 | 07:37

The P/E ratio of Fischer Medical Ventures is 2061.5 As on 29 December, 2024 | 07:37

The PB ratio of Fischer Medical Ventures is 47 As on 29 December, 2024 | 07:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23